Showing Media Items: 1–10 of 14
-
CoLucid Founder Passes Away
-
CoLucid Pharmaceuticals to Present at the Biotech Showcase during J.P. Morgan Healthcare Conference
-
CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
-
CoLucid pockets $4M for PhIII migraine drug trial
-
CoLucid Pharmaceuticals raises $4M
-
CoLucid raises $7.5M for novel migraine headache drug
-
CoLucid Pharmaceuticals raises $7.5 million of planned $9.5
-
CoLucid in Talks with Partners for Novel Migraine Treatment
-
CoLucid Pharmaceuticals, First-in-class CNS drugs
-
Business of Health: CoLucid